Precure Selects Helix as Multiomics Lab and AI Tools Provider
Mayo Clinic recently launched Precure with founding partner Thermo Fisher Scientific to help transform how the life sciences community understands the biological changes that occur as disease develops before symptoms occur. The post Precure Selects Helix as Multiomics Lab and AI Tools Provider appeared first on GEN - Genetic Engineering and Biotechnology News .
Mayo Clinic has partnered with Thermo Fisher Scientific and Helix to launch Precure, a program aiming to accelerate the integration of molecular insights into routine clinical care. Precure will focus on generating genomic information from around one million biospecimens, ultimately aiming to detect diseases early and enable earlier interventions.
Helix will provide advanced AI tools and population-scale multiomic capabilities, including whole genome sequencing and proteome sequencing, linked with clinical data. The collaboration builds upon Mayo Clinic's Tapestry study, which involved Helix's Exome+ sequencing technology, reaching 100,000 participants. Helix's UG200 Ultra Sequencing Platform will be used to generate genomic data for WGS and proteomics at scale.
By combining Helix's laboratory and data capabilities with Mayo Clinic's expertise, the program aims to create a "precision baseline for a lifetime of care."
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
